Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Head of the FDA
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1228)
•••
Comment by CancerSlayeron Nov 22, 2024 11:07pm
177 Views
Post# 36327172

RE:Head of the FDA

RE:Head of the FDA
Pandora wrote:

Dr. Marty McSorley of John's Hopkins has been named as the proposed new head of the FDA.

That is a good appointment. Not sure how long it may take so no idea if it will have an effect on TLT's progress.


It took ~4 months to confirm head of the FDA (Dr. Gottlieb) under the Trump administration in 2016.  Hoepfully, we are on a similar timeline.  Under Biden, it took ~13 months to confirm Dr. Califf.

I'm hoping to see less red tape & less of what has appeared to be an FDA addiction (historically) to Big Pharma's opiate/immunotherapy industry.  What I'd like more of are FDA reviewers & a greater broad-mindedness to the potential of alternative/less traditional therapeutic approaches.  

I also hope the current FDA continues to honor its mission in a timely manner: "to protect public health by ensuring the safety, efficacy, and security of the following products".

JMO

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities